| Product Code: ETC11877095 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
Despite a slight decline in growth rate in 2024, Guatemala`s import shipments of enteric disease testing and therapeutic products continued to show steady growth with a moderate concentration level. Key exporting countries like Japan, USA, China, Germany, and Indonesia played a significant role in supplying these essential goods to Guatemala. The consistent Compound Annual Growth Rate (CAGR) of 1.61% from 2020 to 2024 indicates a stable market demand for such products in the country, reflecting the importance of addressing enteric diseases through testing and therapeutic interventions.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guatemala Enteric Disease Testing and Therapeutic Market Overview |
3.1 Guatemala Country Macro Economic Indicators |
3.2 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Guatemala Enteric Disease Testing and Therapeutic Market - Industry Life Cycle |
3.4 Guatemala Enteric Disease Testing and Therapeutic Market - Porter's Five Forces |
3.5 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.6 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Guatemala Enteric Disease Testing and Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of enteric diseases in Guatemala |
4.2.2 Growing awareness about the importance of early detection and treatment of enteric diseases |
4.2.3 Government initiatives to improve healthcare infrastructure and access to testing and treatment facilities |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in remote areas of Guatemala |
4.3.2 High cost associated with enteric disease testing and treatment |
4.3.3 Lack of skilled healthcare professionals in the field of enteric diseases |
5 Guatemala Enteric Disease Testing and Therapeutic Market Trends |
6 Guatemala Enteric Disease Testing and Therapeutic Market, By Types |
6.1 Guatemala Enteric Disease Testing and Therapeutic Market, By Testing Type |
6.1.1 Overview and Analysis |
6.1.2 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Testing Type, 2021 - 2031F |
6.1.3 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Molecular Testing, 2021 - 2031F |
6.1.4 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Stool Culture, 2021 - 2031F |
6.1.5 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Serological Testing, 2021 - 2031F |
6.1.6 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Rapid Testing Kits, 2021 - 2031F |
6.2 Guatemala Enteric Disease Testing and Therapeutic Market, By Disease Type |
6.2.1 Overview and Analysis |
6.2.2 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Gastroenteritis, 2021 - 2031F |
6.2.3 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Cholera, 2021 - 2031F |
6.2.4 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Salmonella Infection, 2021 - 2031F |
6.2.5 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By E. Coli Infection, 2021 - 2031F |
6.3 Guatemala Enteric Disease Testing and Therapeutic Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.3.4 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.3.5 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Guatemala Enteric Disease Testing and Therapeutic Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antiviral Therapy, 2021 - 2031F |
6.4.3 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Antibiotic Therapy, 2021 - 2031F |
6.4.4 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Probiotic Therapy, 2021 - 2031F |
6.4.5 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Vaccine Therapy, 2021 - 2031F |
6.5 Guatemala Enteric Disease Testing and Therapeutic Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.4 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Online Retail, 2021 - 2031F |
6.5.5 Guatemala Enteric Disease Testing and Therapeutic Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
7 Guatemala Enteric Disease Testing and Therapeutic Market Import-Export Trade Statistics |
7.1 Guatemala Enteric Disease Testing and Therapeutic Market Export to Major Countries |
7.2 Guatemala Enteric Disease Testing and Therapeutic Market Imports from Major Countries |
8 Guatemala Enteric Disease Testing and Therapeutic Market Key Performance Indicators |
8.1 Percentage increase in the number of enteric disease testing facilities in Guatemala |
8.2 Improvement in the average time taken for diagnosis and treatment of enteric diseases |
8.3 Increase in the number of awareness campaigns and educational programs related to enteric diseases in Guatemala |
9 Guatemala Enteric Disease Testing and Therapeutic Market - Opportunity Assessment |
9.1 Guatemala Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
9.2 Guatemala Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.3 Guatemala Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Guatemala Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 Guatemala Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Guatemala Enteric Disease Testing and Therapeutic Market - Competitive Landscape |
10.1 Guatemala Enteric Disease Testing and Therapeutic Market Revenue Share, By Companies, 2024 |
10.2 Guatemala Enteric Disease Testing and Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here